Veradermics is a biotechnology company in the healthcare sector trading on XNYS, led by CEO Reid Waldman, with a market cap of $2.3B.
No upcoming earnings scheduled for Veradermics
No earnings announcement scheduled
Past 1 earnings report for Veradermics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | Q4 2025 | -$0.62Est: -$0.66 | +6.1% | - | — |
We use cookies for analytics. See our Privacy and Cookie Policy.